Sabra Health Care REIT, Inc. Announces Tax Treatment of 2024 Distributions

Business Wire
01-25

TUSTIN, Calif., January 24, 2025--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid:

Sabra Health Care REIT, Inc.

Common Stock (CUSIP # 78573L106)

Record
Date

Payable
Date

Distribution
per Share

Total
Ordinary
Dividends

Non-Qualified
Dividends

Qualified
Dividends

Non-Dividend
Distributions

02/13/2024

02/29/2024

$

0.3000000

$

0.2649911

$

0.2649911

$

0.0000000

$

0.0350089

05/20/2024

05/31/2024

0.3000000

0.2649911

0.2649911

0.0000000

0.0350089

08/19/2024

08/30/2024

0.3000000

0.2649911

0.2649911

0.0000000

0.0350089

11/15/2024

11/29/2024

0.3000000

0.2649911

0.2649911

0.0000000

0.0350089

$

1.2000000

$

1.0599644

$

1.0599644

$

0.0000000

$

0.1400356

100.00%

88.33%

11.67%

The 2024 Non-Qualified Ordinary Dividends are also reported on Form 1099-DIV, Box 5, Section 199A Dividends. Treasury Regulation §1.199A-3(c)(2)(ii) requires that shareholders hold their REIT shares for at least 45 days in order for the dividends to be treated as Section 199A Dividends. Shareholders should consult with their tax advisors to determine whether this requirement affects any portion of the dividends included in Box 5.

Pursuant to Treas. Reg. § 1.1061-6(c), the Company reports that for purposes of section 1061 of the Internal Revenue Code, the One Year Amounts Disclosure and the Three Year Amounts Disclosure are $0.00 with respect to direct and indirect holders of "applicable partnership interests".

About Sabra

Sabra Health Care REIT, Inc. (Nasdaq:SBRA), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250124305467/en/

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10